News Stories

The University of Arizona Cancer Center has completed the initial steps of its search for a new director, identifying five candidates for campus visits and in-depth interviews.

Natalia Ignatenko, PhD

Natalia Ignatenko, PhD, has been awarded $1.6 million by the National Cancer Institute to study the role of Kallikrein 6 in colon cancer.

Alison Stopeck, MD, and Patricia Thompson, PhD, have been awarded $1.7 million by the NIH National Cancer Institute to study NSAID effects on clinical and imaging breast biomarkers.

Funding from the American Cancer Society will assist four new University of Arizona Cancer Center investigators in their research projects.

Representatives of the Colombian National Cancer Institute invited University of Arizona Cancer Center physician-scientists to a three-day conference in Bogota in April attended by about 100 clinicians and researchers to discuss ways to establish a multidisciplinary approach to improve the outcomes of patients treated for melanoma at their institution.

Check out the University of Arizona Cancer Center's new blog, Act Against Cancer, designed to provide timely information about our center and the cancer world.

Cynthia Thomson, PhD, RD, CSO

University of Arizona Cancer Center member Cynthia Thomson, PhD, RD, CSO, has been selected as a winner of the 2011 Huddleson Award for her manuscript, “A Systematic Review of Behavioral Interventions to Promote Intake of Fruit and Vegetables."

Tim and Diane Bowden

When G. Timothy Bowden, PhD, wasn’t hard at work on his many research projects within the University of Arizona Cancer Center’s Cellular and Molecular Medicine program, he could often be found hiking up Mount Lemmon or through the Sabino Canyon trails with his wife, Diane, at his side.

Living in Harmony with the Sun

Join representatives of the UACC's Skin Cancer Institute Saturday at the annual Living in Harmony with the Sun program at the Arizona-Sonora Desert Museum.

Emmanuel Katsanis, MD, with Azayliah D. Perez

Emmanuel Katsanis, MD, has spent the better part of four decades on the leading edge of cancer research. Some of his greatest breakthroughs have occurred while wearing running shoes.